Abstract
(Lancet. 2016;388:2629–2641) Placenta-mediated pregnancy complications include preeclampsia, birth of a small for gestational age (SGA) neonate, placental abruption, and late pregnancy loss. They are significant contributors to maternal and neonatal morbidity and mortality. Patients experiencing these complications are also at risk of placenta-mediated complications occurring in subsequent pregnancies. Effective preventive measures for these complications are generally lacking. The current investigators had previously published a study-level meta-analysis that indicated low–molecular-weight heparin (LMWH) could reduce the risk of recurrence. However, there was significant heterogeneity in that study so they decided to perform an individual patient data meta-analysis to evaluate the efficacy of LMWH to prevent recurrent placenta-mediated complications in subsequent pregnancies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
